Chlamydia pneumoniae infection and thrombotic ischemic stroke

Journal of Isfahan Medical School

Volumn 24, Issue 83, 2007, Pages

  Ashtari, F ^a   Shayegannejad, V ^a   Saberi, Alia ^a   Karkheyran, F ^a   Khosravi, E ^a  

^a ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Chlamydia pneumoniae; Ischemic stroke; Serum antibody

Indexed keywords

IMMUNOGLOBULIN A; IMMUNOGLOBULIN G;

ANTIBODY BLOOD LEVEL; ANTIBODY TITER; ARTICLE; BRAIN ISCHEMIA; CASE CONTROL STUDY; CHLAMYDIAL PNEUMONIA; CONTROLLED STUDY; HUMAN; IMMUNE RESPONSE; MAJOR CLINICAL STUDY; OBSERVATIONAL STUDY;

EID: 85045440406     PISSN: 10277595     EISSN: 1735854X     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Bradley WE, Darroff RB, Fenichel GM, Jankovic J. Neurology in clinical practice. 4 ed. New York: Butterworth-Heinemann, 2004.
2. Mandell GL, Bennett JE, Dolin R. Principles and Practice of Infectious Disease. 5 ed. Philadelphia: Churchill Livingstone, 2000.
3. Sander D, Winbeck K, Klingelhofer J, Etgen T, Conrad B. Reduced progression of early carotid atherosclerosis after antibiotic treatment and Chlamydia pneumoniae seropositivity. Circulation 2002; 106(19):2428-33.
4. Lehr HA, Sagban TA, Kirkpatrick CJ. [Atherosclerosis--progression by nonspecific activation of the immune system]. Med Klin (Munich) 2002; 97(4):229-35.
5. Fryer RH, Schwobe EP, Woods ML, Rodgers GM. Chlamydia species infect human vascular endothelial cells and induce procoagulant activity. J Investig Med 1997; 45(4):168-74.
6. Campbell LA, O’Brien ER, Cappuccio AL, Kuo CC, Wang SP, Stewart D et al. Detection of Chlamydia pneumoniae TWAR in human coronary atherectomy tissues. J Infect Dis 1995; 172(2):585-8.
7. Kuo CC, Grayston JT, Campbell LA, Goo YA, Wissler RW, Benditt EP. Chlamydia pneumoniae (TWAR) in coronary arteries of young adults (15-34 years old). Proc Natl Acad Sci U S A 1995; 92(15):6911-4.
8. Lowry RW, Adam E, Hu C, Kleiman NS, Cocanougher B, Windsor N et al. What are the implications of cardiac infection with cytomegalovirus before heart transplantation? J Heart Lung Transplant 1994; 13(1 Pt 1):122-8.
9. Mendall MA, Goggin PM, Molineaux N, Levy J, Toosy T, Strachan D et al. Relation of Helicobacter pylori infection and coronary heart disease. Br Heart J 1994; 71(5):437-9.
10. Monno R, Di Biase M, Costi A, de Nicolo T, Correale M, Bolognese P et al. [Chlamydia pneumoniae, atherosclerosis, and coronary disease]. Ital Heart J Suppl 2003; 4(5):383-97.
11. Tanne D, Haim M, Boyko V, Goldbourt U, Reshef T, Adler Y et al. Prospective study of Chlamydia pneumoniae IgG and IgA seropositivity and risk of incident ischemic stroke. Cerebrovasc Dis 2003; 16(2):166-70.
12. Heuschmann PU, Neureiter D, Gesslein M, Craiovan B, Maass M, Faller G et al. Association between infection with Helicobacter pylori and Chlamydia pneumoniae and risk of ischemic stroke subtypes: Results from a population-based casecontrol study. Stroke 2001; 32(10):2253-8.
13. Madre JG, Garcia JL, Gonzalez RC, Montero JM, Paniagua EB, Escribano JR et al. Association between seropositivity to Chlamydia pneumoniae and acute ischaemic stroke. Eur J Neurol 2002; 9(3):303-6.
14. Medrano V, Castano MD, Andreu M, Molto JM, Sanchez-Perez RM, Hernandez-Lorido R et al. [The relation between carotid ultrasound changes and seropositivity to Chlamydia pneumoniae in patients with acute stroke]. Rev Neurol 2000; 31(10):932-6.
15. Elkind MS, Lin IF, Grayston JT, Sacco RL. Chlamydia pneumoniae and the risk of first ischemic stroke: The Northern Manhattan Stroke Study. Stroke 2000; 31(7):1521-5.
16. Wolf SC, Mayer O, Jurgens S, Vonthein R, Schultze G, Risler T et al. Chlamydia pneumoniae IgA seropositivity is associated with increased risk for atherosclerotic vascular disease, myocardial infarction and stroke in dialysis patients. Clin Nephrol 2003; 59(4):273-9.
17. Cook PJ, Honeybourne D, Lip GY, Beevers DG, Wise R, Davies P. Chlamydia pneumoniae antibody titers are significantly associated with acute stroke and transient cerebral ischemia: the West Birmingham Stroke Project. Stroke 1998; 29(2):404-10.
18. Wimmer ML, Sandmann-Strupp R, Saikku P, Haberl RL. Association of chlamydial infection with cerebrovascular disease. Stroke 1996; 27(12):2207-10.
19. Corrado E, Rizzo M, Tantillo R, Muratori I, Bonura F, Vitale G et al. Markers of inflammation and infection influence the outcome of patients with baseline asymptomatic carotid lesions: a 5-year follow-up study. Stroke 2006; 37(2):482-6.
20. Anzini A, Cassone A, Rasura M, Ciervo A, Beccia M, Di Lisi F et al. Chlamydia pneumoniae infection in young stroke patients: a case--control study. Eur J Neurol 2004; 11(5):321-7.
21. Gerdes VE, Verkooyen RP, Kwa VI, de Groot E, van Gorp EC, ten Cate H et al. Chlamydial LPS antibodies, intima-media thickness and ischemic events in patients with established atherosclerosis. Atherosclerosis 2003; 167(1):65-71.
22. Ngeh J, Gupta S, Goodbourn C, Panayiotou B, McElligott G. Chlamydia pneumoniae in elderly patients with stroke (C-PEPS): a case-control study on the seroprevalence of Chlamydia pneumoniae in elderly patients with acute cerebrovascular disease. Cerebrovasc Dis 2003; 15(1-2):11-6.
23. Kuo CC, Shor A, Campbell LA, Fukushi H, Patton DL, Grayston JT. Demonstration of Chlamydia pneumoniae in atherosclerotic lesions of coronary arteries. J Infect Dis 1993; 167(4):841-9.
24. Muhlestein JB. Bacterial infections and atherosclerosis. J Investig Med 1998; 46(8):396-402.
25. Saikku P. Chlamydia pneumoniae infection as a risk factor in acute myocardial infarction. Eur Heart J 1993; 14 Suppl K:62-5.
26. Hoiby N, Doring G, Schiotz PO. The role of immune complexes in the pathogenesis of bacterial infections. Annu Rev Microbiol 1986; 40:29-53.
27. Valtonen VV. Infection as a risk factor for infarction and atherosclerosis. Ann Med 1991; 23(5):539-43.
28. Mattila KJ, Valtonen VV, Nieminen MS, Asikainen S. Role of infection as a risk factor for atherosclerosis, myocardial infarction, and stroke. Clin Infect Dis 1998; 26(3):719-34.
29. Rupp J, Berger M, Reiling N, Gieffers J, Lindschau C, Haller H et al. Cox-2 inhibition abrogates Chlamydia pneumoniae-induced PGE2 and MMP-1 expression. Biochem Biophys Res Commun 2004; 320(3):738-44.
30. Kazmierski R, Kozubski W. [Effect of Chlamydia pneumoniae infection on carotid atherosclerosis development]. Neurol Neurochir Pol 2002; 36(1):131-42.
31. Brea A, Mosquera D, Martin E, Arizti A, Cordero JL, Ros E. Nonalcoholic fatty liver disease is associated with carotid atherosclerosis: a casecontrol study. Arterioscler Thromb Vasc Biol 2005; 25(5):1045-50.